Now showing items 1-4 of 4

    • Biomarkers For Epileptogenesis And Its Treatment 

      Engel, Jerome Jr; Pitkänen, Asla (Elsevier BV, 2020)
      There are no pharmacological interventions to prevent the development of epilepsy, although many promising compounds have been identified in the animal laboratory. Clinical trials to validate their effectiveness, however, ...
      Tieteelliset aikakauslehtiartikkelit

    • Elevated acute plasma miR-124-3p level relates to evolution of larger cortical lesion area after traumatic brain injury 

      Vuokila, Niina; Gupta, Shalini Das; Huusko, Riina; Tohka, Jussi; Puhakka, Noora; Pitkänen, Asla (Elsevier BV, 2020)
      Mechanisms initiated by traumatic brain injury (TBI), leading to the development of progressive secondary injury are poorly understood. MicroRNAs (miRNAs) have a proposed role in orchestrating the post-injury aftermath as ...
      Tieteelliset aikakauslehtiartikkelit

    • Epilepsy biomarkers - Toward etiology and pathology specificity 

      Pitkänen, Asla; Ekolle, Ndode-Ekane Xavier; Lapinlampi, Niina; Puhakka, Noora (Elsevier BV, 2019)
      A biomarker is a characteristic that is measured as an indicator of normal biologic processes, pathogenic processes, or responses to an exposure or intervention, including therapeutic interventions. Biomarker modalities ...
      Tieteelliset aikakauslehtiartikkelit

    • MicroRNAs in the regulation of autophagy and their possible use in age-related macular degeneration therapy 

      Hyttinen, Juha M T; Blasiak, Janusz; Felszeghy, Szabolcs; Kaarniranta, Kai (Elsevier BV, 2021)
      Age-related macular degeneration (AMD) is a progressive sight-impairing disease of the elderly. The pathogenic mechanisms of AMD are not well understood although both genetic and many environmental factors have been ...
      Tieteelliset aikakauslehtiartikkelit